 |
|
Efficacy and predictors of the virologic response to entecavir therapy in nucleoside naive patients with chronic hepatitis B
Korean J Hepatol. 2010;16(1):57-65. Published online 2010 Mar 26 DOI: https://doi.org/10.3350/kjhep.2010.16.1.57
|
|
Citations to this article as recorded by
 Predictors of treatment efficacy with nucleos(t)ide analogues for chronic hepatitis B
T. H. Nguyen, L. Yu. Ilchenko, L. I. Melnikova, K. K. Kyuregyan, I. V. Gordeychuk, N. L. Bondarenko
Experimental and Clinical Gastroenterology.2023; (4): 77. CrossRef A long-term multicenter study: Entecavir versus Tenofovir in treatment of nucleos(t)ide analogue-naive chronic hepatitis B patients
Bircan Kayaaslan, Esragul Akinci, Alpay Ari, Zeliha Kocak Tufan, Saygın Nayman Alpat, Ozgur Gunal, Selma Tosun, Rahmet Guner, Fehmi Tabak
Clinics and Research in Hepatology and Gastroenterology.2018; 42(1): 40. CrossRef Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B
Kwan Sik Lee, Young-Oh Kweon, Soon-Ho Um, Byung-Ho Kim, Young Suk Lim, Seung Woon Paik, Jeong Heo, Heon-Ju Lee, Dong Joon Kim, Tae Hun Kim, Young-Sok Lee, Kwan Soo Byun, Daeghon Kim, Myung Seok Lee, Kyungha Yu, Dong Jin Suh
Clinical and Molecular Hepatology.2017; 23(4): 331. CrossRef Comparable efficacy of tenofovir versus entecavir and predictors of response in treatment-naïve patients with chronic hepatitis B: a multicenter real-life study
Ayse Batirel, Ertugrul Guclu, Ferhat Arslan, Funda Kocak, Oguz Karabay, Serdar Ozer, Munevver Turanli, Ali Mert
International Journal of Infectious Diseases.2014; 28: 153. CrossRef Effect of Entecavir in Patients Who Lack Lamivudine Resistance after Lamivudine Treatment for Chronic Hepatitis B
Kyung Ho Ha, Dong Wook Joo, Ji Suk Kim, Byung Seok Kim, Chang Hyeong Lee
Korean Journal of Medicine.2013; 84(6): 810. CrossRef Polymorphism of estrogen receptor alpha (ESR1) is associated with virological response to entecavir (ETV) in nucleoside-naïve adult patients with chronic hepatitis B
T.-T. Zhang, J. Ye, S.-L. Xia, Y.-F. Zhang, Q. Su, Z.-H. Zhang, X. Li
Infection.2013; 41(2): 371. CrossRef Clinical impacts of hazardous alcohol use and obesity on the outcome of entecavir therapy in treatment-naïve patients with chronic hepatitis B infection
Won Gil Chung, Hong Joo Kim, Young Gil Choe, Hyo Sun Seok, Chang Wook Chon, Yong Kyun Cho, Byung Ik Kim, Young Yool Koh
Clinical and Molecular Hepatology.2012; 18(2): 195. CrossRef Pretreatment serum HBsAg-to-HBV DNA ratio predicts a virologic response to entecavir in chronic hepatitis B
Joon Chang Song, Bo Young Min, Jin-Wook Kim, Jong Yeop Kim, Yeo Myeong Kim, Cheol Min Shin, Sang Hyub Lee, Jin-Hyeok Hwang, Sook-Hyang Jeong, Nayoung Kim, Dong Ho Lee
The Korean Journal of Hepatology.2011; 17(4): 268. CrossRef Predictors for virologic response in management of chronic hepatitis B
Jung Min Lee, Sang Hoon Ahn
The Korean Journal of Hepatology.2010; 16(1): 1. CrossRef
|